Literature DB >> 9879820

Usefulness of cyanide-nitroprusside test in detecting incomplete recessive heterozygotes for cystinuria: a standardized dilution procedure.

R Finocchiaro1, P D'Eufemia, M Celli, M Zaccagnini, L Viozzi, P Troiani, O Mannarino, O Giardini.   

Abstract

We present the results of a cyanide-nitroprusside test (CNT) after a standardized dilution procedure of urine samples and report the efficiency of this method in detecting heterozygotes for cystinuria when applied on an open pediatric population. In the preliminary study we assayed by quantitative determination of amino acids 162 urine samples from a hospital population identifying 24 type III heterozygotes and 2 type II heterozygotes for cystinuria. The classic CNT gave 38 false positive results and 5 false negative results showing a sensitivity and specificity of 0.808 and 0.721, respectively. When progressively diluted, all samples of heterozygotes remained CNT positive up to a creatinine concentration of 90 mg/dl. At this level of dilution 31 out of 38 false positive turned to negative, thus obtaining a specificity of 0.922 without a lowering of the sensitivity in detecting heterozygotes. The standardized dilution at 90 mg/dl of creatinine concentration was applied to 74.7% of a population of 1024 schoolchildren. In this way 163 out of 210 positive results were eliminated and thus the specificity of CNT rose from 0.789 to 0.953. On the basis of these results, the method proposed can be regarded as reliable and useful for a screening program in detecting heterozygotes for cystinuria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879820     DOI: 10.1007/s002400050076

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  7 in total

1.  Pilot screening programme for cystinuria in the Valencian community.

Authors:  M L Cabello-Tomás; A M García-Gómez; M L Guillén-Domínguez
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

Review 2.  Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up.

Authors:  Thomas Knoll; Antonia Zöllner; Gunnar Wendt-Nordahl; Maurice Stephan Michel; Peter Alken
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

3.  Phenotypic characterization of a pediatric cohort with cystinuria and usefulness of newborn screening.

Authors:  Juan Alberto Piñero-Fernández; Carmen Vicente-Calderón; María José Lorente-Sánchez; María Jesús Juan-Fita; José María Egea-Mellado; Inmaculada C González-Gallego
Journal:  Pediatr Nephrol       Date:  2022-10-13       Impact factor: 3.651

Review 4.  Cystinuria: an update on pathophysiology, genetics, and clinical management.

Authors:  Viola D'Ambrosio; Giovanna Capolongo; David Goldfarb; Giovanni Gambaro; Pietro Manuel Ferraro
Journal:  Pediatr Nephrol       Date:  2021-11-23       Impact factor: 3.651

Review 5.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

Review 6.  Cystinuria-a urologist's perspective.

Authors:  Kay Thomas; Kathie Wong; John Withington; Matthew Bultitude; Angela Doherty
Journal:  Nat Rev Urol       Date:  2014-03-25       Impact factor: 14.432

7.  Infrared vibrational spectroscopy: a rapid and novel diagnostic and monitoring tool for cystinuria.

Authors:  Katherine V Oliver; Annalisa Vilasi; Amandine Maréchal; Shabbir H Moochhala; Robert J Unwin; Peter R Rich
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.